Evidence map›Paper›PMID 26834728›Full record

ReviewFrontiers in microbiology2016

Therapeutic Application of Synbiotics, a Fusion of Probiotics and Prebiotics, and Biogenics as a New Concept for Oral Candida Infections: A Mini Review.

Tomoko Ohshima, Yukako Kojima, Chaminda J Seneviratne, Nobuko Maeda

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
14.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 88 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Isolation and characterization ofFrontiers in veterinary science · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Effect ofFrontiers in nutrition · 2024
    Article
  10. Article
  11. Influence of the ProbioticMicroorganisms · 2023
    Review
  12. The Role of the Oral Microbiome in the Development of Diseases.International journal of molecular sciences · 2023
    Review
  13. Article
  14. Probiotic Species in the Management of Periodontal Diseases: An Overview.Frontiers in cellular and infection microbiology · 2022
    Review
  15. Review
  16. Review
  17. Article
  18. Application of Probiotic Yeasts onJournal of fungi (Basel, Switzerland) · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Tomoko OhshimaDepartment of Oral Microbiology, School of Dental Medicine, Tsurumi University Kanagawa, Japan.
Yukako KojimaDepartment of Oral Microbiology, School of Dental Medicine, Tsurumi University Kanagawa, Japan.
Chaminda J SeneviratneDepartment of Oral Sciences, Faculty of Dentistry, National University of Singapore Singapore, Singapore.
Nobuko MaedaDepartment of Oral Microbiology, School of Dental Medicine, Tsurumi University Kanagawa, Japan.
Tsurumi University · JPNational University of Singapore · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Candida is a major human fungal pathogen causing infectious conditions predominantly in the elderly and immunocompromised hosts. Although Candida resides as a member of the oral indigenous microbiota in symbiosis, some circumstances may cause microbial imbalance leading to dysbiosis and resultant oral candidiasis. Therefore, oral microbial symbiosis that suppresses the overgrowth of Candida is important for a healthy oral ecosystem. In this regard, probiotics, prebiotics, and synbiotics can be considered a potential therapeutic and preventive strategy against oral candidiasis. Prebiotics have a direct effect on microbial growth as they stimulate the growth of beneficial bacteria and suppress the growth of pathogens. Probiotics render a local protective effect against pathogens and a systemic indirect effect on immunological amelioration. Synbiotics are fusion products of prebiotics and probiotics. This mini review discusses the potential use and associated limitations of probiotics, prebiotics, and synbiotics for the prevention and treatment of oral candidiasis. We will also introduce biogenics, a recent concept derived from the work on probiotics. Biogenics advocates the use of beneficial bioactive substances produced by probiotic bacteria, whose activities are independent from the viability of probiotic bacteria in human bodies.

Indexed as

biogenicslactobacillioral candidiasisprebioticsprobioticssynbiotics

Identifiers

PMID26834728
PMCPMC4724717
OpenAlexW2268127647

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.